Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:CHE
CUSIP16359R10
Phone513-762-6690
Debt
Debt-to-Equity Ratio0.19
Current Ratio1.04
Quick Ratio1.01
Price-To-Earnings
Trailing P/E Ratio59.71
Forward P/E Ratio28.96
P/E Growth2.88
Sales & Book Value
Annual Sales$1.67 billion
Price / Sales3.09
Cash Flow$8.0145 per share
Price / Cash39.93
Book Value$33.84 per share
Price / Book9.46
Profitability
EPS (Most Recent Fiscal Year)$5.36
Net Income$98.17 million
Net Margins11.00%
Return on Equity33.57%
Return on Assets19.11%
Miscellaneous
Employees14,813
Outstanding Shares16,090,000
Market Cap$5.12 billion
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Friday, August 3rd. Shareholders of record on Monday, August 13th will be paid a dividend of $0.30 per share on Friday, August 31st. This represents a $1.20 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date of this dividend is Friday, August 10th. This is a positive change from Chemed's previous quarterly dividend of $0.28. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed declared that its Board of Directors has approved a share repurchase plan on Wednesday, March 7th 2018, which authorizes the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company's board of directors believes its stock is undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) posted its earnings results on Wednesday, July, 25th. The company reported $2.81 earnings per share for the quarter, beating analysts' consensus estimates of $2.77 by $0.04. The company earned $441.80 million during the quarter, compared to analysts' expectations of $434.28 million. Chemed had a return on equity of 33.57% and a net margin of 11.00%. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.15 EPS. View Chemed's Earnings History.
When is Chemed's next earnings date?
What guidance has Chemed issued on next quarter's earnings?
Chemed issued an update on its FY18 earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of $11.35-11.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.16.
What price target have analysts set for CHE?
3 equities research analysts have issued 1 year target prices for Chemed's stock. Their predictions range from $275.00 to $321.00. On average, they anticipate Chemed's share price to reach $298.00 in the next twelve months. This suggests that the stock has a possible downside of 6.9%. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemed.
Who are some of Chemed's key competitors?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)
- Mr. David P. Williams, Exec. VP & CFO (Age 57)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 64)
- Mr. Spencer S. Lee, Exec. VP (Age 62)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 39)
Has Chemed been receiving favorable news coverage?
News headlines about CHE stock have been trending positive on Wednesday, according to Accern Sentiment Analysis. The research group scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chemed earned a media and rumor sentiment score of 0.28 on Accern's scale. They also gave news headlines about the company an impact score of 46.70 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for Chemed.
Who are Chemed's major shareholders?
Chemed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.62%), Acadian Asset Management LLC (3.56%), Riverbridge Partners LLC (3.17%), FMR LLC (3.06%), Fisher Asset Management LLC (3.01%) and Gamco Investors INC. ET AL (1.75%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Summit Trail Advisors LLC, Gamco Investors INC. ET AL, Voya Investment Management LLC, Dimensional Fund Advisors LP, Van Berkom & Associates Inc. and Gabelli Funds LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Point72 Asset Management L.P., Virginia Retirement Systems ET AL, Renaissance Technologies LLC, Citadel Advisors LLC, Bank of Nova Scotia, Jane Street Group LLC and Tibra Equities Europe Ltd. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $320.02.
How big of a company is Chemed?
Chemed has a market capitalization of $5.12 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
